1 | Bosentan (D01227) | [1] Bosentan Bosentan | [2] Bosentan
Bosentan
(D01227),
Bosentan
💬
| [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [11] 40 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
|
2 | Bosentan 125 MG (D01227) | [1] Bosentan Bosentan | [2] Bosentan
Bosentan
(D01227),
Bosentan
💬
| [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬
|
3 | Bosentan 62.5 MG (D01227) | [1] Bosentan Bosentan | [2] Bosentan
Bosentan
(D01227),
Bosentan
💬
| [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬
|
4 | Bosentan administration (D01227) | [1] Bosentan Bosentan | [2] Bosentan
Bosentan
(D01227),
Bosentan
💬
| [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
5 | Bosentan dispersible tablets (D01227) | [1] Bosentan Bosentan | [2] Bosentan
Bosentan
(D01227),
Bosentan
💬
| [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
6 | Bosentan group (D01227) | [1] Bosentan Bosentan | [2] Bosentan
Bosentan
(D01227),
Bosentan
💬
| [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬
|
7 | Bosentan monohydrat (D01227) | [1] Bosentan Bosentan | [2] Bosentan
Bosentan
(D01227),
Bosentan
💬
| [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
8 | Bosentan monohydrate (D01227) | [1] Bosentan Bosentan | [2] Bosentan
Bosentan
(D01227),
Bosentan
💬
| [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [4] 51 51, 84, 86, 88 💬
|
9 | Bosentan mylan (D01227) | [1] Bosentan Bosentan | [2] Bosentan
Bosentan
(D01227),
Bosentan
💬
| [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 41 41 💬
|
10 | Bosentan, ambrisentan (D01227) | [1] Bosentan Bosentan | [2] Bosentan
Bosentan
(D01227),
Bosentan
💬
| [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
11 | DUO-therapy with sildenafil + bosentan (D01227) | - | - | - | - | [1] 86 86 💬
|
12 | Sildenafil 20MG and bosentan 62.5MG (D01227) | [1] Sildenafil Sildenafil | [2] Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| [1] PDE5 PDE5 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [2] 51 51, 86 💬
|
13 | Sildenafil singly or IN association with bosentan (D01227) | [1] Sildenafil Sildenafil | [2] Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| [1] PDE5 PDE5 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|